Skip to main content

Transcend Wealth Collective, LLC

SEC CIK
0001776082
Latest filing
Aug 4, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Transcend Wealth Collective, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
29,656
Value
$7.46M
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Transcend Wealth Collective, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202629,656$7.46M0.5%+1,189+4.2%AddedHolders
Q1 202628,467$6.19M0.5%−961−3.3%ReducedHolders
Q4 202529,428$6.72M0.5%−3,328−10.2%ReducedHolders
Q3 202532,756$7.58M0.5%−5,623−14.7%ReducedHolders
Q2 202538,379$7.12M0.6%−3,798−9.0%ReducedHolders
Q1 202542,177$8.84M0.6%−883−2.1%ReducedHolders
Q4 202443,060$7.65M0.6%−3,303−7.1%ReducedHolders
Q3 202446,363$9.16M0.6%+136+0.3%AddedHolders
Q2 202446,227$7.93M0.6%+17,559+61.2%AddedHolders
Q1 202428,668$5.22M0.4%+6,775+30.9%AddedHolders
Q4 202321,893$3.39M0.3%−256−1.2%ReducedHolders
Q3 202322,149$3.30M0.3%−246−1.1%ReducedHolders
Q2 202322,395$3.02M0.3%+339+1.5%AddedHolders
Q1 202322,056$3.52M0.4%−415−1.8%ReducedHolders
Q4 202222,471$3.63M0.4%−654−2.8%ReducedHolders
Q3 202223,125$3.10M0.3%+132+0.6%AddedHolders
Q2 202222,993$3.52M0.4%−343−1.5%ReducedHolders
Q1 202223,336$3.78M0.3%+813+3.6%AddedHolders
Q4 202122,523$3.05M0.3%+623+2.8%AddedHolders
Q3 202121,900$2.40M0.2%+2,626+13.6%AddedHolders
Q2 202119,274$2.17M0.3%+1,430+8.0%AddedHolders
Q1 202117,844$1.94M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.